Type 1 diabetes mellitus (T1DM) is a chronic autoimmune disease associated with the destruction of pancreatic β cells, which leads to extreme or absolute insulin deficiency. People with T1DM require lifelong insulin therapy. T1DM is a major public health problem with increasing prevalence worldwide (1, 2).
The increase in knowledge of type 1 diabetes over the past 25 years has led to a broad understanding of many aspects of the disease, including genetics, epidemiology, the phenotype of immune cells, and beta cells and the burden of disease. Globally, type 1 diabetes is increasing in both prevalence and incidence, with an overall annual increase in occurrence of about 2–3% per year (3).
However, the incidence of type 1 diabetes varies by country and by region within countries (4). For example, at northern latitudes, people born in the spring are more likely to develop the disease than those born in the other seasons (5).
Type 1 diabetes mellitus is one of the most common chronic diseases that develops in childhood. For unknown reasons, its incidence in children increases from 3 to 5% every year worldwide (6) .The peak incidence of diagnosis is seen in children aged 10–14 years (3, 4).
On the other hand, diabetes is the most common chronic metabolic disease diagnosed in children and adolescents. Although diabetes is not contagious, it is the first and only disease that the United Nations has designated as a 21st century epidemic (6).
However, no reliable data are available on the prevalence of diabetes in many countries (7). The results of international research (DIAMOND and EURODIAB) reveal an increasing trend in Diabetes prevalence in most regions of the world, with the highest growth dynamics in the youngest age group (6, 7).
The global increase in T1DM prevalence is a well-known fact; with the highest rate reported from fast developing countries (8, 9).
Infants experience many changes in their diet in the first year of life. In many cases, their diet initially consists exclusively of breast milk, but gradually shifts from being entirely liquid (breast milk, cow milk, and formula) to also a variety of solid foods (10, 11). Research has shown that using cow milk in infancy increases the risk of β-cell autoimmunity, probably because of the similarity of the molecular sequence of cow milk proteins with the body’s own antigens (12, 13). According to several studies, introducing gluten or cereals, fruits, roots, and seeds to the food before 3 months of age is a risk factor for the autoimmunity to the islets of Langerhans (14, 15). Solid foods can also play a pathogenic role in the development of T1DM in the same way as hypothesized for cow milk (12). Some have recommended that to reduce the risk of immunodeficiency disorders, complementary foods should be added to breast milk starting from the age of 4 to 6 months (14).
However, numerous epidemiological reports have linked the increased risk of T1DM to short breastfeeding period and early introduction of cow milk, formula, or complementary foods to the baby’s diet (14, 16, 17).
It is widely recommended to continue exclusively breastfeeding for the first 4 to 6 months of the infant's life. Research has confirmed the health benefits of this breastfeeding and also continued breastfeeding during the first year of life. In any case, it is not recommended to start complementary feeding before 4 months of age (10, 14, 16, 17).
With the increasing prevalence of T1DM worldwide, the management and treatment of this disease and its acute and chronic complications are imposing significant burdens on patients as well as health care systems (18, 19). In this study, the objective was to investigate the potential relationships between T1DM and infant’s diet in the first two years of life as well as some demographic variables.